GUILFORD, Conn., Feb. 24, 2022 (GLOBE NEWSWIRE) — InveniAI® LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery...
LOUISVILLE, Ky., Feb. 24, 2022 (GLOBE NEWSWIRE) — Healthcare is hard. And, when it comes to HCC Risk Adjustment, obstacles like inefficiencies & inaccuracies often crop...
New York, NY, Feb. 24, 2022 (GLOBE NEWSWIRE) — The Association for Computing Machinery’s global Technology Policy Council (ACM TPC) today released, “ACM TechBrief: Facial Recognition,”...
THE WOODLANDS, Texas, Feb. 24, 2022 (GLOBE NEWSWIRE) — via InvestorWire — SPYR, Inc. dba SPYR Technologies (OTCQB: SPYR) (https://spyr.com), a technology company whose subsidiary, Applied...
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) — The “Neobanking Market Size, Share & Trends Analysis Report by Account Type (Business, Savings), by Application (Enterprises, Personal), by...
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-β OT-101 has completed over six clinical trials against solid tumors with good efficacy OT-101 is currently undergoing a phase...
SALT LAKE CITY, Feb. 24, 2022 (GLOBE NEWSWIRE) — OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions...
Detroit, Michigan, Feb. 24, 2022 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD)...
Appointment accelerates Company’s development roadmap in targeted therapies for neuropsychiatric disorders The Head of the Statistical Genetics Research Group at Max-Planck-Institute of Psychiatry in Munich is...
Ehave has licensed AI technology from Vastmindz for MetaHealthU. in 2022, Ehave plans to monetize the AI technology it licensed from Vastmindz to expand the Ehave...